MS vs SER · P/E 20, $344.27B cap vs rev $56.0K
Morgan Stanley (MS) versus Serina Therapeutics Inc (SER) — a side-by-side from cached financials, not a winner call.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
MS does not have a complete income-statement cache yet.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
MS currently screens at market cap $344.27B and trailing P/E 19.8. SER currently screens at market cap $29.7M.
Not investment advice. Open the MS and SER stock pages for the full models.
Not investment advice.